21st Annual NATA Symposium Scientific Programme

Choose your Timezone (Toggle Map):

Day 1

12 Apr 2021

Day 2

13 Apr 2021

Day 3

14 Apr 2021

Day 4

15 Apr 2021

Day 5

16 Apr 2021

09:00 - 10:00 CEST

SESSION 1A

SAFETY OF BLOOD AND BLOOD PRODUCTS

Chairs: Maria Beatrice Rondinelli, Rome, Italy; Helen V. New, London, UK; Cheuk-Kwong Lee, Hong Kong, China

09:00 - 09:15 CEST

Transfusion-related immunomodulation – theoretical or clinically relevant?

David Baron, Vienna, Austria

Baron, David

09:15 - 09:30 CEST

Pathogen testing in 2021 – what is necessary?

Maria Beatrice Rondinelli, Rome, Italy

Rondinelli, Maria Beatrice

09:30 - 09:45 CEST

Age of blood – problem solved or ongoing debate?

Philip C. Spinella, St. Louis, MO, USA

Spinella, Philip C.

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 2A

HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE

Chairs: Jens Meier, Linz, Austria; Young Jin Yuh, Seoul, South Korea; Alexander Vlaar, Amsterdam, The Netherlands

11:30 - 11:45 CEST

How to approach liberal vs. restrictive transfusion

Anders Møller, Slagelse, Denmark

Møller, Anders

11:45 - 12:00 CEST

Transfusion strategy in myocardial infarction – REALITY trial

Philippe Gabriel Steg, Paris, France

Steg, Philippe Gabriel

12:00 - 12:15 CEST

Whole blood – now or never?

Jakob Stensballe, Copenhagen, Denmark

12:15 - 12:30 CEST

Discussion

13:15 - 13:45 CEST

Best Poster session

BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 1)

Chairs: Jens Meier, Linz, Austria; Helen V. New, London, UK

13:15 - 13:20 CEST

Erythrocytes inhibit T-cell activation by modulation of redox state

Marlene C. Gerner, Vienna, Austria

13:20 - 13:25 CEST

Intraoperative cell salvage as an alternative to allogeneic blood transfusion: an evaluation of the immune response profile

Michelle Roets, Brisbane, QLD, Australia

13:25 - 13:30 CEST

Combined intraoperative platelet and erythrocyte salvage: first evaluation of a new autotransfusion device

Alexandre Mansour, Rennes, France

13:30 - 13:35 CEST

Cell salvage: A decade of haemovigilance reporting in the UK

Sarah Haynes, Manchester, UK

13:35 - 13:45 CEST

Discussion

15:45 - 16:15 CEST

Best Poster session

BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 2)

Chairs: Elvira Bisbe, Barcelona, Spain; Ignacio Sarmiento Goldberg, Providencia, Chile

15:45 - 15:50 CEST

Blood donation and transfusion during the first wave of COVID-19 pandemic in Spain: different impact according to autonomous communities and hospitals

José Antonio García-Erce, Pamplona, Spain

15:50 - 15:55 CEST

McCluskey risk index application to blood transfusion needs in liver transplantation at Coimbra Hospital and University Center ‒ Is blood transfusion no more unpredictable?

Sílvia Amaral, Coimbra, Portugal

15:55 - 16:00 CEST

Should we continue routine preoperative blood ordering in orthopaedic surgery?

Eva Bassas Parga, Barcelona, Spain

16:00 - 16:05 CEST

A descriptive Blood sample Volume Analysis in a Multidisciplinary Pediatric Intensive caRE unit (B-VAMPIRE)

Tine François, Montreal, QC, Canada

16:05 - 16:15 CEST

Discussion

17:00 - 18:00 CEST

SESSION 3A

PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE

Chairs: Elvira Bisbe, Barcelona, Spain; Nicole R. Guinn, Durham, NC, USA; Hanne Berg Ravn, Copenhagen, Denmark

17:00 - 17:15 CEST

The basics of PBM – pillar 1

Ane Abad Motos, Madrid, Spain

Abad Motos, Ane

17:15 - 17:30 CEST

The basics of PBM – pillar 2

Dania Fischer, Frankfurt, Germany

Fischer, Dania

17:30 - 17:45 CEST

The basics of PBM – pillar 3

Tina Tomić Mahečić, Zagreb, Croatia

Tomić Mahečić, Tina

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 4A

HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION

Chair: Sigismond Lasocki, Angers, France; Christian von Heymann, Berlin, Germany; José A. García-Erce, Pamplona, Spain

19:30 - 19:45 CEST

Top 5 most important PBM publications in 2020–2021

David Faraoni, Toronto, ON, Canada

Faraoni, David

19:45 - 20:00 CEST

RCTs in PBM – do they give us all the answers?

Kevin Trentino, Perth, WA, Australia

Trentino, Kevin

20:00 - 20:15 CEST

Maturity Assessment in PBM – monitoring implementation at the national level

Elvira Bisbe, Barcelona, Spain

Bisbe, Elvira

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 3B

PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE

Chairs: Sigismond Lasocki, Angers, France; Jameela Sathar, Selangor, Malaysia; Giovanni Inghilleri, Milan, Italy

09:00 - 09:15 CEST

The basics of PBM – pillar 1

Ane Abad Motos, Madrid, Spain

Abad Motos, Ane

09:15 - 09:30 CEST

The basics of PBM – pillar 2

Dania Fischer, Frankfurt, Germany

Fischer, Dania

09:30 - 09:45 CEST

The basics of PBM – pillar 3

Tina Tomić Mahečić, Zagreb, Croatia

Tomić Mahečić, Tina

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 4B

HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION

Chair: Manuel Muñoz, Málaga, Spain; Daniela Filipescu, Bucharest, Romania; Jeong-jae Lee, Seoul, South Korea

11:30 - 11:45 CEST

Top 5 most important PBM publications in 2020–2021

David Faraoni, Toronto, ON, Canada

Faraoni, David

11:45 - 12:00 CEST

RCTs in PBM – do they give us all the answers?

Kevin Trentino, Perth, WA, Australia

Trentino, Kevin

12:00 - 12:15 CEST

Maturity Assessment in PBM – monitoring implementation at the national level

Elvira Bisbe, Barcelona, Spain

Bisbe, Elvira

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 1B

SAFETY OF BLOOD AND BLOOD PRODUCTS

Chairs: Beverley J. Hunt, London, UK; Jeannie Callum, Toronto, ON, Canada; Jerrold H. Levy, Durham, NC, USA

17:00 - 17:15 CEST

Transfusion-related immunomodulation – theoretical or clinically relevant?

David Baron, Vienna, Austria

Baron, David

17:15 - 17:30 CEST

Pathogen testing in 2021 – what is necessary?

Maria Beatrice Rondinelli, Rome, Italy

Rondinelli, Maria Beatrice

17:30 - 17:45 CEST

Age of blood – problem solved or ongoing debate?

Philip C. Spinella, St. Louis, MO, USA

Spinella, Philip C.

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 2B

HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE

Chairs: Jean-François Hardy, Montreal, QC, Canada; Jeffrey L. Carson, New Brunswick, NJ, USA; Ludhmila Abrahão Hajjar, São Paulo, SP, Brazil

19:30 - 19:45 CEST

How to approach liberal vs. restrictive transfusion

Anders Møller, Slagelse, Denmark

Møller, Anders

19:45 - 20:00 CEST

Transfusion strategy in myocardial infarction – REALITY trial

Philippe Gabriel Steg, Paris, France

Steg, Philippe Gabriel

20:00 - 20:15 CEST

Whole blood – now or never?

Jakob Stensballe, Copenhagen, Denmark

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 5A

CELL SALVAGE – OUTDATED OR UP TO DATE?

Chairs: Toby Richards, Perth, WA, Australia; Jonghyeon Lee, Seoul, South Korea; Thomas Frietsch, Mannheim, Germany

09:00 - 09:15 CEST

Cell salvage in paediatrics

Susan M. Goobie, Boston, MA, USA

Goobie, Susan

09:15 - 09:30 CEST

Cell salvage in the bleeding trauma patient

Lidia Mora Miquel, Barcelona, Spain

Mora Miquel, Lidia

09:30 - 09:45 CEST

Cell salvage in cancer surgery – a no go?

Timo Seyfried, Regensburg, Germany

Seyfried, Timo

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 6A

HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY

Chairs: Maria Beatrice Rondinelli, Rome, Italy; Dongho Choi, Seoul, South Korea; Bernd Froessler, Adelaide, SA, Australia

11:30 - 11:45 CEST

The anaemia clinic – a must for every hospital

Elvira Bisbe, Barcelona, Spain

Bisbe, Elvira

11:45 - 12:00 CEST

Preoperative IV iron in major abdominal surgery: PREVENTT trial

Toby Richards, Perth, WA, Australia

Richards, Toby

12:00 - 12:15 CEST

EPO – a new kid on the block?

Sigismond Lasocki, Angers, France

Lasocki, Sigismond

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 7A

PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?

Chairs: Jens Meier, Linz, Austria; Aryeh Shander, Englewood, NJ, USA, Marcel Levi, London, UK

17:00 - 17:15 CEST

WHO Action framework for blood products – focus on PBM

Yuyun Maryuningsih, Geneva, Switzerland

Maryuningsih, Yuyun

17:15 - 17:30 CEST

Levels of PBM implementation – a global view

Axel Hofmann, Zurich, Switzerland

Hofmann, Axel

17:30 - 17:45 CEST

Stakeholders’ perspectives on PBM

Jens Meier, Linz, Austria

Meier, Jens

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 8

SABM SESSION – A PRACTICAL APPROACH TO PATIENT BLOOD MANAGEMENT

Chairs: Carolyn Burns, Louisville, KY, USA; Charles-Marc Samama, Paris, France; Jean-François Hardy, Montreal, QC, Canada

19:30 - 19:45 CEST

The role of the surgeon in PBM

Pierre Tibi, Prescott, AZ, USA

Tibi, Pierre

19:45 - 20:00 CEST

The role of a PBM coordinator

Sherri Ozawa, Englewood, NJ, USA

Ozawa, Sherri

20:00 - 20:15 CEST

Wind of change – how to initiate PBM in real life?

Aryeh Shander, Englewood, NJ, USA

Shander, Aryeh

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 7B

PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?

Chairs: Elvira Bisbe, Barcelona, Spain; Ananthi Krishnamoorthy, Ipoh, Perak, Malaysia; Kai Zacharowski, Frankfurt, Germany

09:00 - 09:15 CEST

WHO Action framework for blood products – focus on PBM

Yuyun Maryuningsih, Geneva, Switzerland

Maryuningsih, Yuyun

09:15 - 09:30 CEST

Role of the European Union in promoting PBM

Axel Hofmann, Zurich, Switzerland

Hofmann, Axel

09:30 - 09:45 CEST

Stakeholders’ perspectives on PBM

Jens Meier, Linz, Austria

Meier, Jens

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 9

ASPBM SESSION – INSIGHT INTO PATIENT BLOOD MANAGEMENT IN ASIA

Chairs: Jeong-jae Lee, Seoul, South Korea; Jaewhoan Koh, Gyeonggi, South Korea; Jens Meier, Linz, Austria

11:30 - 11:45 CEST

PBM in South Korea and the birth of ASPBM

Jong-Hoon Park, Seoul, South Korea

Park, Jong-Hoon

11:45 - 12:00 CEST

PBM in China: a nationwide endeavour

Hongwen Ji, Beijing, China

Ji, Hongwen

12:00 - 12:15 CEST

PBM – the Challenge of unmet needs in Asia

Angelina Gapay, Tacloban City, Leyte, Philippines

Gapay, Angelina

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 10A

PATIENT BLOOD MANAGEMENT IN THE ICU

Chairs: David Faraoni, Toronto, ON, Canada; Augusto Pérez-Calatayud, Mexico City, Mexico; Howard L. Corwin, Danville, PA, USA

17:00 - 17:15 CEST

Role of iron and EPO in the ICU

Sigismond Lasocki, Angers, France

Lasocki, Sigismond

17:15 - 17:30 CEST

Coagulopathies in the ICU

Isabell Pekrul, Munich, Germany

Pekrul, Isabell

17:30 - 17:45 CEST

Transfusion triggers for critically ill patients – ESICM guidelines

Alexander P. J. Vlaar, Amsterdam, The Netherlands

Vlaar, Alexander P. J.

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 11A

HOT TOPICS IV – BLEEDING AND THROMBOSIS

Chairs: Charles-Marc Samama, Paris, France; Ignacio Sarmiento Goldberg, Providencia, Chile; Fredy Ariza Cadena, Cali, Colombia

19:30 - 19:45 CEST

When to use tranexamic acid?

Beverley J. Hunt, London, UK

19:45 - 20:00 CEST

Point-of-care coagulation monitoring – the way to go

Jakob Stensballe, Copenhagen, Denmark

20:00 - 20:15 CEST

COVID-19, haemostasis and thrombosis

Beverley J. Hunt, London, UK

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 10B

PATIENT BLOOD MANAGEMENT IN THE ICU

Chairs: Jens Meier, Linz, Austria; Kiew Kong Pau, Kuala Lumpur, Malaysia; Shunji Kawamoto, Kanagawa, Japan

09:00 - 09:15 CEST

Role of iron and EPO in the ICU

Sigismond Lasocki, Angers, France

Lasocki, Sigismond

09:15 - 09:30 CEST

Coagulopathies in the ICU

Isabell Pekrul, Munich, Germany

Pekrul, Isabell

09:30 - 09:45 CEST

Transfusion triggers for critically ill patients – ESICM guidelines

Alexander P. J. Vlaar, Amsterdam, The Netherlands

Vlaar, Alexander P. J.

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 11B

HOT TOPICS IV – BLEEDING AND THROMBOSIS

Chairs: Charles-Marc Samama, Paris, France; Elisavet Grouzi, Athens, Greece; Byung-Hoon Yoo, Seoul, South Korea

11:30 - 11:45 CEST

When to use tranexamic acid?

Beverley J. Hunt, London, UK

11:45 - 12:00 CEST

Point-of-care coagulation monitoring – the way to go

Jakob Stensballe, Copenhagen, Denmark

12:00 - 12:15 CEST

COVID-19, haemostasis and thrombosis

Beverley J. Hunt, London, UK

12:15 - 12:30 CEST

Discussion

12:35 - 13:05 CEST

Best Poster session

BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 3)

Chairs: Sigismond Lasocki, Angers, France; Bernd Froessler, Adelaide, SA, Australia

12:35 - 12:40 CEST

Iron deficiency reduces mitochondrial respiration and changes mitochondrial morphology in mouse skeletal muscle tissue

Katerina Cabolis, London, UK

12:40 - 12:45 CEST

A retrospective cohort review of pre-operative anaemia and postoperative outcomes in 1,751 colorectal surgical patients

Charlotte Oliver, Cardiff, Wales, UK

12:45 - 12:50 CEST

Comparison of two intravenous iron regimens in the treatment of postoperative anaemia after colorectal cancer surgery

Marta De la Rosa-Estadella, Barcelona, Spain

12:50 - 12:55 CEST

Evaluation of serum phosphate levels in surgical patients receiving intravenous ferric carboxymaltose

Linda K. Wijaya, Perth, WA, Australia

12:55 - 13:05 CEST

Discussion

15:45 - 16:15 CEST

Best Poster session

BEST POSTERS ‒ ORAL COMMUNICATIONS (PART 4)

Chairs: Maria Beatrice Rondinelli, Rome, Italy; Jakob Stensballe, Copenhagen, Denmark

15:45 - 15:50 CEST

The need to screen for anaemia in fit and healthy women

Cory Dugan, Perth, WA, Australia

15:50 - 15:55 CEST

Charting the course of ‘Gynaemia’ (Patients with Anaemia undergoing Gynaecological Onco-surgery)

Sandaruwani Abeysiri, London, UK

15:55 - 16:00 CEST

Early plasma transfusion and maternal outcomes in women with postpartum haemorrhage: Does the amount of resuscitation fluids matter?

Johanna van der Bom, Leiden, The Netherlands

16:00 - 16:05 CEST

Procoagulant membrane dynamics: a novel approach to identify platelet activation in pre-eclampsia

Joshua Nicholas, Calgary, AB, Canada

16:05 - 16:15 CEST

Discussion

17:00 - 18:00 CEST

SESSION 5B

CELL SALVAGE – OUTDATED OR UP TO DATE?

Chairs: David Faraoni, Toronto, ON, Canada; Jonathan H. Waters, Pittsburgh, PA, USA; Thorsten Haas, Zurich, Switzerland

17:00 - 17:15 CEST

Cell salvage in paediatrics

Susan M. Goobie, Boston, MA, USA

Goobie, Susan

17:15 - 17:30 CEST

Cell salvage in the bleeding trauma patient

Lidia Mora Miquel, Barcelona, Spain

Mora Miquel, Lidia

17:30 - 17:45 CEST

Cell salvage in cancer surgery – a no go?

Timo Seyfried, Regensburg, Germany

Seyfried, Timo

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 6B

HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY

Chairs: Manuel Muñoz, Málaga, Spain; Michael Auerbach, Baltimore, MD, USA

19:30 - 19:45 CEST

The anaemia clinic – a must for every hospital

Elvira Bisbe, Barcelona, Spain

Bisbe, Elvira

19:45 - 20:00 CEST

Preoperative IV iron in major abdominal surgery: PREVENTT trial

Toby Richards, Perth, WA, Australia

Richards, Toby

20:00 - 20:15 CEST

EPO – a new kid on the block?

Sigismond Lasocki, Angers, France

Lasocki, Sigismond

20:15 - 20:30 CEST

Discussion

* CEST, Central European Summer Time (UTC +2)